Financial Contrast: Teladoc Health (NYSE:TDOC) vs. OptimizeRx (NASDAQ:OPRX)

OptimizeRx (NASDAQ:OPRX – Get Free Report) and Teladoc Health (NYSE:TDOC – Get Free Report) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, risk, dividends, valuation and earnings.

Profitability

This table compares OptimizeRx and Teladoc Health’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
OptimizeRx 5.33% 9.58% 7.47%
Teladoc Health -6.27% -11.63% -5.53%

Analyst Ratings

This is a summary of recent ratings and recommmendations for OptimizeRx and Teladoc Health, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
OptimizeRx 1 2 6 0 2.56
Teladoc Health 2 11 5 0 2.17

OptimizeRx currently has a consensus price target of $11.21, indicating a potential upside of 57.70%. Teladoc Health has a consensus price target of $8.53, indicating a potential downside of 3.09%. Given OptimizeRx’s stronger consensus rating and higher probable upside, analysts clearly believe OptimizeRx is more favorable than Teladoc Health.

Valuation and Earnings

This table compares OptimizeRx and Teladoc Health”s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
OptimizeRx $109.43 million 1.22 $5.13 million $0.25 28.44
Teladoc Health $2.47 billion 0.65 -$200.32 million ($0.86) -10.24

OptimizeRx has higher earnings, but lower revenue than Teladoc Health. Teladoc Health is trading at a lower price-to-earnings ratio than OptimizeRx, indicating that it is currently the more affordable of the two stocks.

Insider and Institutional Ownership

76.5% of OptimizeRx shares are held by institutional investors. Comparatively, 76.8% of Teladoc Health shares are held by institutional investors. 7.5% of OptimizeRx shares are held by company insiders. Comparatively, 0.7% of Teladoc Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Risk and Volatility

OptimizeRx has a beta of 1.2, suggesting that its share price is 20% more volatile than the S&P 500. Comparatively, Teladoc Health has a beta of 2, suggesting that its share price is 100% more volatile than the S&P 500.

Summary

OptimizeRx beats Teladoc Health on 11 of the 14 factors compared between the two stocks.

About OptimizeRx

(Get Free Report)

OptimizeRx is a healthcare technology company that connects life sciences companies with healthcare professionals and patients through digital communications. Its platform uses channels such as electronic health records and other clinical workflows to deliver relevant information at the point of care. The company’s services support programs for medication access and affordability, patient education and engagement, and communication between healthcare providers and life sciences organizations. OptimizeRx also provides tools intended to help life sciences companies reach clinicians and patients through digital channels.

About Teladoc Health

(Get Free Report)

Teladoc Health, Inc. provides virtual healthcare services through a digital platform that connects individuals with clinicians and other health professionals. Its offerings include virtual primary and specialty care, mental health services, and support for managing chronic conditions. The company serves members in the United States and internationally, with services and availability varying by market. Its consumer mental health services include BetterHelp, while its chronic-care programs draw on technology and services developed by Livongo, which Teladoc acquired in 2020.

Receive News & Ratings for OptimizeRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OptimizeRx and related companies with MarketBeat.com's FREE daily email newsletter.